Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients-Reference-Cited by-同舟云学术

Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients

Published:2012-06-05 Issue:9 Volume:87 Page:870-874
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Solimando Maria,Baronciani Luciano,La Marca Silvia,Cozzi Giovanna,Asselta Rosanna,Canciani Maria Teresa,Federici Augusto B.,Peyvandi Flora

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23265/fullpdf

Reference31 articles.

1. von Willebrand factor and von Willebrand disease;Ruggeri;Blood,1987

2. Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand's disease in western Europe and Israel;Mannucci;Br J Haematol,1984

3. Impact, diagnosis and treatment of von Willebrand disease;Sadler;Thromb Haemost,2000

4. Clinical, Laboratory, and Molecular Markers of Type 3 von Willebrand Disease

5. Gene deletions correlate with the development of alloantibodies in von Willebrand disease;Shelton-Inloes;J Clin Invest,1987

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and Bioinformatic Strategies to Improve Diagnosis in Three Inherited Bleeding Disorders in Bogotá, Colombia;Genes;2021-11-18

2. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS;Blood Advances;2021-08-05

3. The Current Understanding of Molecular Pathogenesis of Quantitative von Willebrand Disease, Types 1 and 3;Hämostaseologie;2020-01-22

4. Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor;Haematologica;2019-07-18

5. Von Willebrand disease mutation spectrum and associated mutation mechanisms;Thrombosis Research;2017-11